| 概念识别码 | 药物声明来源 | 药物声明名称 | 药物名称 |
|---|
|
GuideToPharmacology |
348353658 |
|
|
GuideToPharmacology |
178100731 |
|
|
TTD |
PMID25666693-Compound-126 |
|
|
GuideToPharmacology |
178101927 |
|
|
GuideToPharmacology |
135650445 |
|
|
GuideToPharmacology |
135652346 |
|
|
TALC |
XL999 |
|
|
GuideToPharmacology |
135650441 |
|
|
TTD |
Botulinum Toxin Type A |
|
|
GuideToPharmacology |
135651141 |
|
|
TTD |
Ketoheterocycle derivative 4 |
|
|
GuideToPharmacology |
249565791 |
|
|
TTD |
PMID30107136-Compound-Example58 |
|
|
NCI |
TAXANES |
|
|
TTD |
NKP 608 |
|
|
NCI |
PHOSPHOROTHIOATE OLIGONUCLEOTIDE |
|
|
TTD |
BLU-554 |
|
|
TTD |
Cycloalkyl nitrile pyrazolo pyridone derivative 1 |
|
|
TTD |
TG003 |
|
|
NCI |
ZINC CHLORIDE |
|
|
TdgClinicalTrial |
LINAGLIPTON |
|
|
GuideToPharmacology |
223365904 |
|
|
TTD |
Human interleukin-2 |
|
|
TTD |
Sulfonamides |
|
|
TEND |
FLUOCINOLONE ACETONIDE |
|
|
GuideToPharmacology |
178100615 |
|
|
GuideToPharmacology |
178103552 |
|
|
GuideToPharmacology |
135650508 |
|
|
PharmGKB |
Antihypertensives And Diuretics In Combination |
|
|
TTD |
Insulin Susp Protamine Zinc Beef/Pork |
|
|
GuideToPharmacology |
310264792 |
|
|
GuideToPharmacology |
178102931 |
|
|
TTD |
PIKAMILONE |
|
|
CIViC |
JAK2 INHIBITOR AZD1480 |
|
|
GuideToPharmacology |
178102451 |
|
|
TTD |
PMID25522065-Compound-45 |
|
|
NCI |
RETINYL PALMITATE |
|
|
CIViC |
MEK INHIBITOR PD0325901 |
|
|
GuideToPharmacology |
252827466 |
|
|
TTD |
US9024044, 1 |
|
|
TTD |
C7R-GD2.CART cells |
|
|
GuideToPharmacology |
178102531 |
|
|
TTD |
AZD-7268 |
|
|
GuideToPharmacology |
336446932 |
|
|
GuideToPharmacology |
178102486 |
|
|
TdgClinicalTrial |
ZYC300 |
|
|
TTD |
Pyrazole derivative 2 |
|
|
NCI |
LIPOSOMAL DOXORUBICIN |
|
|
GuideToPharmacology |
178101360 |
|
|
TTD |
CT84.66 |
|
|
TTD |
SMT-D002 |
|
|
TTD |
CART-38 cells |
|
|
GuideToPharmacology |
315661317 |
|
|
GuideToPharmacology |
178100330 |
|
|
TTD |
Guanadrel Sulfate |
|
|
TTD |
HEV-239 |
|
|
TTD |
Imidazopyridine derivative 6 |
|
|
TTD |
Recombinant factor VIIa PEGylated liposomal |
|
|
TTD |
PMID29649907-Compound-25 |
|
|
TTD |
Imidazo bicyclic iminium derivative 3 |
|
|
TTD |
DdRNAi therapy rHIV7-shl-TAR-CCR5RZ, stem cells |
|
|
GuideToPharmacology |
249565849 |
|
|
TTD |
GS-4977 |
|
|
GuideToPharmacology |
252166805 |
|
|
GuideToPharmacology |
135651222 |
|
|
FDA |
Ascorbic Acid |
|
|
GuideToPharmacology |
252166516 |
|
|
GuideToPharmacology |
363894133 |
|
|
TTD |
BDBM50080563 |
|
|
TdgClinicalTrial |
CNDO101 |
|
|
TALC |
RETASPIMYCIN HYDROCHLORIDE |
|
|
GuideToPharmacology |
178100726 |
|
|
GuideToPharmacology |
178100774 |
|
|
TTD |
PMID27019002-Compound-31a |
|
|
GuideToPharmacology |
328083530 |
|
|
TTD |
TOL-3021 |
|
|
TTD |
Interferon Alfa-2a, Recombinant |
|
|
TTD |
US9409892, 59 |
|
|
GuideToPharmacology |
135652625 |
|
|
TTD |
PMID29757691-Compound-2a-i |
|
|
TTD |
DWP-09031 |
|
|
NCI |
SILICON PHTHALOCYANINE 4 |
|
|
GuideToPharmacology |
178103591 |
|
|
JAX-CKB |
SBI-0640756 |
|
|
GuideToPharmacology |
135649996 |
|
|
TTD |
PMID27109571-Compound-10 |
|
|
TTD |
Insulin oral sublingual |
|
|
GuideToPharmacology |
252166758 |
|
|
TTD |
Bis-sulfonamide derivative 2 |
|
|
GuideToPharmacology |
336446924 |
|
|
TTD |
US8598210, Table XV, 2 |
|
|
TdgClinicalTrial |
AVI-5126 |
|
|
TTD |
PMID25772215-Compound-US02014179750TG7-112-2 |
|
|
TTD |
US9340511, 2 |
|
|
GuideToPharmacology |
135650519 |
|
|
TTD |
GSK2646264 |
|
|
NCI |
MAPK INHIBITORS |
|
|
TTD |
APD-209 |
|
|
GuideToPharmacology |
178101072 |
|
|
GuideToPharmacology |
178102915 |
|
|
TdgClinicalTrial |
RECOMBINANT INTERFERON ALFA-2B |
|
|
TEND |
COAGULATION FACTOR VIIA |
|
|
GuideToPharmacology |
252166863 |
|
|
TTD |
US9006244, E2b |
|
|
GuideToPharmacology |
135651171 |
|
|
TTD |
Tricyclic pyrrolidine derivative 1 |
|
|
TTD |
Bidentate ligands of Markush derivative 2 |
|
|
NCI |
ACE INHIBITOR |
|
|
TTD |
Epoetin alfa |
|
|
TTD |
PMID26651364-Compound-8d |
|
|
TTD |
US9611221, Example 9 |
|
|
TTD |
Aminopyridine derivative 2 |
|
|
GuideToPharmacology |
178100848 |
|
|
GuideToPharmacology |
329968391 |
|
|
GuideToPharmacology |
405560328 |
|
|
GuideToPharmacology |
135651744 |
|
|
TTD |
Boswellia acid derivative 1 |
|
|
TTD |
KITE-585 |
|
|
TTD |
Benzoic acid linked peptide analog 2 |
|
|
GuideToPharmacology |
249565824 |
|
|
TTD |
CD19 and CD22 CAR-T Cells |
|
|
TTD |
ALF-5755 |
|
|
TTD |
Protein A mimetics |
|
|
TTD |
Pyrrolo[2,3-d]pyrimidine derivative 17 |
|
|
TTD |
US10077269, Example 6 |
|
|
TTD |
Carboxamide derivative 9 |
|
|
TTD |
PMID28270021-Compound-WO2010077680 803 |
|
|
TTD |
Heteroaryl-carboxamide derivative 5 |
|
|
TTD |
BDBM50158794 |
|
|
JAX-CKB |
EGFRBi-armed autologous activated T cells |
|
|
TTD |
PD-157695 |
|
|
TTD |
NKTR 214 |
|
|
TTD |
AMG 172 |
|
|
TTD |
PMID25399762-Compound-Table1-C10 |
|
|
GuideToPharmacology |
135650657 |
|
|
TdgClinicalTrial |
XL844 |
|
|
GuideToPharmacology |
178102800 |
|
|
TTD |
Biphenyl mannoside derivative 18 |
|
|
TTD |
PMID27774824-Compound-Figure7Example10 |
|
|
TTD |
PMID29334795-Compound-61 |
|
|
TTD |
TRBC1 |
|
|
TTD |
CAR-T cells targeting CD38 |
|
|
TTD |
PMID26666989-Compound-Figure11Ala up |
|
|
GuideToPharmacology |
178101063 |
|
|
NCI |
PROTEIN PHOSPHATASE INHIBITOR |
|
|
TTD |
Tacrine-phenothiazine hybrid derivative 1 |
|
|
TTD |
GSK-1827771 |
|
|
GuideToPharmacology |
135650542 |
|
|
TTD |
ABC294640 |
|
|
TTD |
1,5-diphenylpyrrolidin-2-one derivative 2 |
|
|
GuideToPharmacology |
375973227 |
|
|
TTD |
Phytocannabinoid/aminoalkylindole derivative 1 |
|
|
TTD |
PMID28454500-Compound-34 |
|
|
GuideToPharmacology |
223366043 |
|
|
TTD |
Oxazolo[3,4-a]pyrazine derivative 2 |
|
|
TTD |
Leukocyte interleukin |
|
|
GuideToPharmacology |
135651993 |
|
|
TTD |
PMID27841036-Compound-33 |
|
|
TTD |
PMID29338548-Compound-48 |
|
|
TTD |
QGC-001 |
|
|
GuideToPharmacology |
404859113 |
|
|
TTD |
AN-019 |
|
|
TdgClinicalTrial |
LORVOTUZUMAB |
|
|
TTD |
PMID28870136-Compound-58 |
|
|
GuideToPharmacology |
135650471 |
|
|
GuideToPharmacology |
178100556 |
|
|
GuideToPharmacology |
135652142 |
|
|
TTD |
PMID29865878-Compound-39 |
|
|
GuideToPharmacology |
178102532 |
|
|
TTD |
ATryn antithrombin |
|
|
TTD |
CSP-1103 |
|
|
TTD |
Indoline derivative 14 |
|
|
TTD |
Tetra-hydro-pyrazolopyrazine derivative 2 |
|
|
TTD |
3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivative 5 |
|
|
GuideToPharmacology |
178101065 |
|
|
TTD |
Prolixin decanoate |
|
|
TTD |
ELND-004 |
|
|
NCI |
AG 879 |
|
|
GuideToPharmacology |
135652751 |
|
|
NCI |
TGF-BETA 2 |
|
|
TTD |
BAY 1067197 |
|
|
GuideToPharmacology |
252166709 |
|
|
GuideToPharmacology |
178101032 |
|
|
TTD |
US9656955, Example 652 |
|
|
TTD |
US8933228, 3 |
|
|
TTD |
FKB01MD |
|
|
TTD |
PTG-100 |
|
|
TTD |
Salicylic acid derivative 5 |
|
|
GuideToPharmacology |
135652383 |
|
|
GuideToPharmacology |
178102900 |
|
|
GuideToPharmacology |
135651357 |
|
|
TTD |
PMID25666693-Compound-15 |
|
|
NCI |
DIC10 |
|
|
TTD |
AZD4831 |
|
|
CIViC |
FACT COMPLEX-TARGETING CURAXIN CBL0137 |
|
|
TTD |
F4co vaccine |
|
|
GuideToPharmacology |
381744946 |
|
|
GuideToPharmacology |
135651608 |
|
|
GuideToPharmacology |
135652496 |
|
|
GuideToPharmacology |
135652445 |
|
|
GuideToPharmacology |
252166808 |
|
|
GuideToPharmacology |
178102197 |
|
|
TTD |
KUR-111 |
|
|
GuideToPharmacology |
223365913 |
|
|
GuideToPharmacology |
318164804 |
|
|
TTD |
IW-6118 |
|
|
NCI |
MCP-1 |
|
|
GuideToPharmacology |
135651611 |
|
|
GuideToPharmacology |
249565887 |
|
|
TTD |
Ethacrynic acid |
|
|
GuideToPharmacology |
178101471 |
|
|
NCI |
NORMAL SALINE |
|
|
TTD |
BDBM50363780 |
|
|
CIViC |
AZD5438 |
|
|
TTD |
PMID25666693-Compound-135 |
|
|
GuideToPharmacology |
252166504 |
|
|
TTD |
RG7741 |
|
|
TTD |
AP-301-IH |
|
|
TTD |
XP-23829 |
|
|
PharmGKB |
thiazolidinediones |
|
|
NCI |
TUMOR VACCINES |
|
|
TTD |
LY3012212 |
|
|
TTD |
YM-264 |
|
|
TTD |
Cyclic sulfonamide derivative 3 |
|
|
GuideToPharmacology |
135652299 |
|
|
TTD |
Quinazoline derivative 4 |
|
|
TTD |
alpha-ketothiazole analogue 36 |
|
|
GuideToPharmacology |
315661298 |
|
|
TdgClinicalTrial |
BREVAREX MAB |
|
|
TTD |
DS-1150b |
|
|
TTD |
PMID25747044-Compound-miRNA |
|
|
GuideToPharmacology |
135650572 |
|
|
TTD |
ZT-1 |
|
|
GuideToPharmacology |
135652606 |
|
|
TTD |
Selenium compound 2 |
|
|
GuideToPharmacology |
135651442 |
|
|
TTD |
TTP-448 |
|
|
TTD |
MRX34 |
|
|
TTD |
T-2007 |
|
|
TTD |
SUN-101 |
|
|
PharmGKB |
vitamin b-complex, plain |
|
|
JAX-CKB |
CCT241161 |
|
|
GuideToPharmacology |
328083487 |
|
|
TTD |
ONO-AE1-437 |
|
|
TTD |
Neugranin |
|
|
TTD |
LMP-1/LMP-2 CTLs |
|
|
GuideToPharmacology |
363894134 |
|
|
TTD |
PMID25435285-Compound-43 |
|
|
TTD |
A-substituted phenylpropionic acid derivative 2 |
|
|
GuideToPharmacology |
252166843 |
|
|
TTD |
CXL |
|
|
TTD |
N-phenyl-pyridine-2-carboxamide derivative 1 |
|
|
GuideToPharmacology |
252166670 |
|
|
TTD |
Dihydropyrido pyrazinone compound 2 |
|
|
TTD |
Org-43902 |
|
|
TTD |
Tetra-hydro-oxazolopyridine derivative 4 |
|
|
GuideToPharmacology |
223366163 |
|
|
TTD |
PGF2ALPHA-IE |
|
|
TTD |
US10174026, Example 99 |
|
|
GuideToPharmacology |
336446957 |
|
|
GuideToPharmacology |
178100295 |
|
|
TTD |
PMID27841045-Compound-137 |
|
|
GuideToPharmacology |
135652284 |
|
|
TTD |
Pyrrolo[2,3-b]pyridine derivative 4 |
|
|
NCI |
METHYLENE BLUE |
|
|
GuideToPharmacology |
249565759 |
|
|
TTD |
P-coumaric acid derivative 5 |
|
|
GuideToPharmacology |
363894167 |
|
|
GuideToPharmacology |
178102831 |
|
|
TTD |
PMID28394193-Compound-38 |
|
|
GuideToPharmacology |
348353664 |
|
|
NCI |
GP39 |
|
|
GuideToPharmacology |
249565684 |
|
|
TTD |
PMID25666693-Compound-82 |
|
|
TTD |
PMID26651364-Compound-126c |
|
|
GuideToPharmacology |
178100909 |
|
|
TTD |
US9353089, 330 |
|
|
GuideToPharmacology |
178103308 |
|
|
TTD |
Taberminogene vadenovec |
|
|
NCI |
INTERFERON GAMMA |
|
|
TTD |
Azaindole derivative 7 |
|
|
TTD |
AMG 282 |
|
|
GuideToPharmacology |
404859125 |
|
|
GuideToPharmacology |
178101177 |
|
|
TTD |
Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivative 3 |
|
|
TTD |
NI-0101 |
|
|
TTD |
BIBH 1 |
|
|
TTD |
JNJ-54728518 |
|
|
TdgClinicalTrial |
R667 |
|
|
TdgClinicalTrial |
TRPV1 ANTAGONIST |
|
|
TTD |
Gp100:209-217(210M) peptide vaccine |
|
|
TTD |
Hydroxyqunoline analog 3 |
|
|
ClearityFoundationClinicalTrial |
PKI-591 |
|
|
TTD |
Azaindazole derivative 3 |
|
|
NCI |
INTERFERON ALPHA-2A |
|
|
GuideToPharmacology |
178102182 |
|
|
TTD |
PMID26651364-Compound-6b |
|
|
JAX-CKB |
NSC348884 |
|
|
CIViC |
PD173074 |
|
|
TTD |
INCAGN1876 |
|
|
GuideToPharmacology |
249565610 |
|
|
GuideToPharmacology |
135651780 |
|
|
PharmGKB |
ezetimibe / simvastatin |
|
|
GuideToPharmacology |
135650634 |
|
|
TTD |
Azetidine derivative 3 |
|
|
TTD |
Guanilib |
|
|
TTD |
PMID28394193-Compound-13 |
|
|
GuideToPharmacology |
249565790 |
|
|
TTD |
NN1841 |
|
|
NCI |
BUTYLATED HYDROXYTOLUENE |
|
|
GuideToPharmacology |
381744925 |
|
|
TdgClinicalTrial |
SPP635 |
|
|
TdgClinicalTrial |
NRP290 |
|
|
TTD |
Pyrazolo[1,5-a]pyrimidine derivative 21 |
|
|
TdgClinicalTrial |
ANAVEX 2-73 |
|
|
PharmGKB |
sofosbuvir / velpatasvir / voxilaprevir |
|
|
TTD |
CD19-CAR T Cells |
|
|
NCI |
RTGF-BETA |
|
|
GuideToPharmacology |
135652415 |
|
|
GuideToPharmacology |
178101078 |
|
|
TTD |
CTAP-201 |
|
|
TTD |
US8586571, 6 |
|
|
GuideToPharmacology |
135651181 |
|
|
TTD |
PMID30107136-Compound-Example47 |
|
|
NCI |
GOSERELIN ACETATE |
|
|
GuideToPharmacology |
381744909 |
|
|
TTD |
PMID26560530-Compound-33 |
|
|
TTD |
1,2,4-triazole derivative 2 |
|
|
TTD |
PMID25435179-Compound-WO2012106509CAY10602 |
|
|
GuideToPharmacology |
135651414 |
|
|
GuideToPharmacology |
178100540 |
|
|
TTD |
Isofagomine tartrate |
|
|
TdgClinicalTrial |
HUPERZINE-A |
|
|
GuideToPharmacology |
404859043 |
|
|
TTD |
PMID28270021-Compound-WO2013009582Example16 |
|
|
TTD |
Heterocyclic derivative 18 |
|
|
TTD |
Coxsackievirus A21 |
|
|
JAX-CKB |
SBI-060756 |
|
|
TTD |
CART-BCMA |
|
|
GuideToPharmacology |
315661116 |
|
|
GuideToPharmacology |
252827408 |
|
|
NCI |
INTERLEUKIN-1-BETA |
|
|
GuideToPharmacology |
135651125 |
|
|
TTD |
Imidazopyridine and triazolopyridine compound 4 |
|
|
GuideToPharmacology |
178102708 |
|
|
GuideToPharmacology |
178103213 |
|
|
TTD |
Medusa IL-2 |
|
|
GuideToPharmacology |
249565674 |
|
|
TTD |
RG7116 |
|
|
TTD |
PMID25482888-Compound-13 |
|
|
GuideToPharmacology |
178102385 |
|
|
JAX-CKB |
PF-573328 |
|
|
TTD |
Mycophenolic acid/nucleotide derivative 9 |
|
|
TTD |
Heteroaromatic ring derivative 3 |
|
|
TTD |
XL652/XL014 |
|
|
TTD |
2-cyclopropyl-4-substituted-phenoxy-quinoline derivative 1 |
|
|
TTD |
PMID25399762-Compound-Table1-C8 |
|
|
GuideToPharmacology |
178100641 |
|
|
PharmGKB |
propionic acid derivatives |
|
|
GuideToPharmacology |
375973223 |
|
|
TTD |
CAR-T Cells targeting CD19 |
|
|
TTD |
LCAR-B38M CAR-T Cell |
|
|
TTD |
INCAGN1949 |
|
|
GuideToPharmacology |
135651659 |
|
|
GuideToPharmacology |
385612222 |
|
|
TTD |
CLS006 |
|
|
GuideToPharmacology |
381744950 |
|
|
TTD |
Tarnylcypromine derivative 2 |
|
|
TTD |
Shigamabs |
|
|
TTD |
Pyrrolo[2,3-d]pyrimidine derivative 14 |
|
|
TTD |
KRDULPYOVRWKMA-UHFFFAOYSA-N |
|
|
TTD |
Peptide analog 56 |
|
|
NCI |
POLYPHENOL |
|
|
TdgClinicalTrial |
DIVALPROEX SODIUM |
|
|
TTD |
Carbamate derivative 4 |
|
|
GuideToPharmacology |
178102467 |
|
|
TTD |
BAY1834845 |
|
|
PharmGKB |
lidocaine and tetracaine |
|
|
TdgClinicalTrial |
FACTOR VIII |
|
|
TTD |
Diphemanil Methylsulfate |
|
|
TTD |
Pfizer 4 |
|
|
TTD |
RG7880 |
|
|
GuideToPharmacology |
404859118 |
|
|
TTD |
L-694,458 |
|
|
NCI |
ANTICONVULSANTS |
|
|
TTD |
Solithromycin oral |
|
|
GuideToPharmacology |
178102747 |
|
|
TTD |
PMID26560530-Compound-54 |
|
|
TTD |
ADMVA |
|
|
TTD |
US9422240, 1-297 |
|
|
GuideToPharmacology |
329968401 |
|
|
GuideToPharmacology |
178100708 |
|
|
NCI |
GONADOTROPIN-RELEASING HORMONE ANALOG |
|
|
TTD |
IQ-DAA |
|
|
TdgClinicalTrial |
GLYCOPYRRONIUM BROMIDE |
|
|
GuideToPharmacology |
252827445 |
|
|
GuideToPharmacology |
329968383 |
|
|
GuideToPharmacology |
178100705 |
|
|
NCI |
ANTITHYMOCYTE GLOBULIN |
|
|
TTD |
4-aryl quinol derivative 3 |
|
|
TTD |
APG-115 |
|
|
PharmGKB |
arteether |
|
|
TTD |
CER-522 |
|
|
JAX-CKB |
AZ960 |
|
|
GuideToPharmacology |
135649706 |
|
|
GuideToPharmacology |
135650223 |
|
|
GuideToPharmacology |
178102271 |
|
|
GuideToPharmacology |
381744959 |
|
|
TTD |
TRYPAN BLUE |
|
|
TTD |
Pyrazolopyrimidine derivative 3 |
|
|
TTD |
PMID27454349-Compound-100 |
|
|
GuideToPharmacology |
178102879 |
|
|
TTD |
Imidazopyridine and triazolopyridine compound 1 |
|
|
TTD |
Peptide analog 16 |
|
|
GuideToPharmacology |
318164802 |
|
|
TTD |
SCHEMBL15295829 |
|
|
GuideToPharmacology |
135650494 |
|
|
GuideToPharmacology |
252166651 |
|
|
TTD |
Cyclic cyanoethypypazole derivative 1 |
|
|
TTD |
PMID25666693-Compound-35 |
|
|
NCI |
N-METHYL-N-NITROSOUREA |
|
|
TEND |
ARDEPARIN |
|
|
GuideToPharmacology |
178100449 |
|
|
GuideToPharmacology |
178102646 |
|
|
GuideToPharmacology |
178100691 |
|
|
TTD |
Cyclic pyranopterin monophosphate |
|
|
TTD |
Crestor/TriLipix |
|
|
GuideToPharmacology |
178102250 |
|
|
TTD |
AFTVac |
|
|
TTD |
BAY-85-8102 |
|
|
PharmGKB |
radiotherapy |
|
|
TTD |
Coumaricacid |
|
|
TTD |
Quinoxaline derivative 4 |
|
|
GuideToPharmacology |
135649874 |
|
|
GuideToPharmacology |
223366027 |
|
|
GuideToPharmacology |
135652497 |
|
|
TTD |
Guanidine Hydrochloride |
|
|
JAX-CKB |
HG-6-63-01 |
|
|
TdgClinicalTrial |
MDX-1401 |
|
|
TTD |
PMID25991433-Compound-K2 |
|
|
GuideToPharmacology |
135650653 |
|
|
TTD |
CPH-102 |
|
|
GuideToPharmacology |
135650718 |
|
|
NCI |
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS |
|
|
GuideToPharmacology |
252166722 |
|
|
PharmGKB |
vitamin c |
|
|
TTD |
GSK618334 |
|
|
GuideToPharmacology |
223366217 |
|
|
TTD |
PMID28594589-Compound-TABLE3C12 |
|
|
GuideToPharmacology |
178100638 |
|
|
TTD |
MEDI9929 |
|
|
TTD |
Heteroaryl-cyclopropylamine derivative 2 |
|
|
TdgClinicalTrial |
DC-RTS-IL-12 |
|
|
GuideToPharmacology |
329968433 |
|
|
GuideToPharmacology |
381744897 |
|
|
TTD |
PMID27967267-Compound-12 |
|
|
GuideToPharmacology |
252166802 |
|
|
TTD |
PMID26560530-Compound-46 |
|
|
TTD |
Aryl mannoside derivative 20 |
|
|
TTD |
PMID25522065-Compound-16 |
|
|
GuideToPharmacology |
178101972 |
|
|
TTD |
Glucagon recombinant |
|
|
GuideToPharmacology |
252166507 |
|
|
GuideToPharmacology |
178102972 |
|
|
TTD |
XL475 |
|
|
TTD |
MSDC-0602 |
|
|
TTD |
Azetidine urea derivative 3 |
|
|
TTD |
PXS-25 |
|
|
PharmGKB |
tipiracil hydrochloride |
|
|
TTD |
1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivative 4 |
|
|
GuideToPharmacology |
135652247 |
|
|
GuideToPharmacology |
249565842 |
|
|
NCI |
IFN |
|
|
PharmGKB |
certolizumab pegol |
|
|
TTD |
CART-123 cells |
|
|
TTD |
Diazepinone derivative 2 |
|
|
TTD |
AC-262271 |
|
|
CIViC |
C-MET INHIBITOR |
|
|
TTD |
Cyclohexyl carbamate derivative 8 |
|
|
TTD |
MK-8342 |
|
|
TTD |
ONO-4232 |
|
|
TTD |
PMID25553724-Compound-US2011000295210 |
|
|
GuideToPharmacology |
404859086 |
|
|
TTD |
BOS172722 |
|
|
GuideToPharmacology |
223366133 |
|
|
GuideToPharmacology |
135650970 |
|
|
TTD |
PMID28350212-Compound-21 |
|
|
GuideToPharmacology |
135649861 |
|
|
TTD |
ET-1 |
|
|
PharmGKB |
8-oxo-dgtp |
|
|
TTD |
KA2507 |
|
|
TTD |
TGFK09SD-ER |
|
|
NCI |
ADENOVIRAL VECTOR |
|
|
TTD |
PMID27539678-Compound-14 |
|
|
GuideToPharmacology |
178102200 |
|
|
TTD |
PMID27744724-Compound-26 |
|
|
TTD |
ISIS 113715 |
|
|
TTD |
PMID28092474-Compound-34a |
|
|
TTD |
PMID26161698-Compound-44 |
|
|
TTD |
PMID28092474-Compound-34 |
|
|
TTD |
PMID29053063-Compound-5 |
|
|
GuideToPharmacology |
178101691 |
|
|
TTD |
PMID29671355-Compound-73 |
|
|
TTD |
US8772478, 1 |
|
|
TTD |
AK107 |
|
|
GuideToPharmacology |
135652591 |
|
|
GuideToPharmacology |
315661343 |
|
|
GuideToPharmacology |
178103156 |
|
|
GuideToPharmacology |
178101724 |
|
|
GuideToPharmacology |
252166783 |
|
|
TTD |
Syntropin |
|
|
TTD |
PMID25726713-Compound-16 |
|
|
TTD |
Tricyclic indole compound 5 |
|
|
GuideToPharmacology |
135651029 |
|
|
GuideToPharmacology |
252827411 |
|
|
TTD |
Biaryl mannoside derivative 21 |
|
|
TTD |
CART-Muc1 cells |
|
|
TTD |
PMID27977313-Compound-17 |
|
|
TTD |
JNJ-63709178 |
|
|
GuideToPharmacology |
135652331 |
|
|
TTD |
PMID30107136-Compound-Example59 |
|
|
TTD |
PF-885706 |
|
|
GuideToPharmacology |
135652266 |
|
|
GuideToPharmacology |
178100844 |
|
|
GuideToPharmacology |
135650169 |
|
|
TTD |
PMID26666989-Compound-Figure9bottomright |
|
|
TTD |
Azaindazole derivative 4 |
|
|
TTD |
US8772478, 5 |
|
|
TTD |
Tricyclic compound 8 |
|
|
TTD |
JES-9501 |
|
|
GuideToPharmacology |
135650948 |
|
|
NCI |
INTERLEUKIN-11 |
|
|
TTD |
4SCAR19 cells |
|
|
TTD |
Dextrothyroxine Sodium |
|
|
GuideToPharmacology |
315661106 |
|
|
GuideToPharmacology |
387065612 |
|
|
GuideToPharmacology |
178100751 |
|
|
TTD |
PMID25435285-Compound-52 |
|
|
TTD |
Pyrazolo[3,4-c]pyridine derivative 1 |
|
|
TTD |
Biphenyl carboxamidopropanoic acid derivative 3 |
|
|
GuideToPharmacology |
135652328 |
|
|
GuideToPharmacology |
178101115 |
|
|
TTD |
DAS-431 IV |
|
|
TTD |
PMID26815044-Compound-125 |
|
|
GuideToPharmacology |
178100613 |
|
|
TTD |
DNA vaccine, Memorial Sloan-Kettering Cancer Center |
|
|
GuideToPharmacology |
135650642 |
|
|
TTD |
SSR-504734 |
|
|
GuideToPharmacology |
381744945 |
|
|
TTD |
AC1LE05K |
|
|
TTD |
PMID25399762-Compound-Table1-C17 |
|
|
TTD |
Synthetic hypericin |
|
|
GuideToPharmacology |
135651327 |
|
|
NCI |
MNU |
|
|
JAX-CKB |
BBI608 |
|
|
GuideToPharmacology |
178102857 |
|
|
TTD |
N-alkyl-4-oxazolecar boxamide derivative 2 |
|
|
GuideToPharmacology |
135651793 |
|
|
GuideToPharmacology |
340590273 |
|
|
GuideToPharmacology |
178103187 |
|
|
GuideToPharmacology |
178101067 |
|
|
TdgClinicalTrial |
CERTOLIZUMAB PEGOL |
|
|
TTD |
ETX-9101 |
|
|
TTD |
PMID27109571-Compound-22 |
|
|
TTD |
Iron Dextran |
|
|
GuideToPharmacology |
385612246 |
|
|
TTD |
Rituxan Immunology |
|
|
GuideToPharmacology |
135650912 |
|
|
TTD |
1,2,4-triazole [1,5-a]pyrimidin-7-yl derivative 3 |
|
|
GuideToPharmacology |
387065584 |
|
|
TdgClinicalTrial |
AM-103 |
|
|
GuideToPharmacology |
223366144 |
|
|
GuideToPharmacology |
178102474 |
|
|
TTD |
Metocurine Iodide |
|
|
TTD |
Spiroimidazolone derivative 2 |
|
|
TTD |
PMID28092474-Compound-32j |
|
|
GuideToPharmacology |
135650776 |
|
|
TTD |
PMID28766366-Compound-Scheme5 |
|
|
TTD |
PMID28051882-Compound-Figure9 |
|
|
TTD |
Cyclopropyl-spiro piperidine derivative 3 |
|
|
ChemblInteractions |
CHEMBL3545099 |
|
|
GuideToPharmacology |
135650752 |
|
|
GuideToPharmacology |
178103144 |
|
|
GuideToPharmacology |
249565857 |
|
|
TTD |
Metal complex derivative 3 |
|
|
TTD |
Bicyclo-heptan-2-amine derivative 3 |
|
|
TTD |
US9217012, 10 |
|
|
TTD |
Pyrazole derivative 13 |
|
|
GuideToPharmacology |
135650423 |
|
|
GuideToPharmacology |
135650408 |
|
|
TTD |
US8759338, 1 |
|
|
GuideToPharmacology |
385612192 |
|
|
GuideToPharmacology |
318164856 |
|
|
GuideToPharmacology |
135650630 |
|
|
TTD |
Biphenyl mannoside derivative 17 |
|
|
TTD |
Isoquinoline sulfonamide derivative 2 |
|
|
GuideToPharmacology |
135651888 |
|
|
TdgClinicalTrial |
STRONTIUM RANELATE |
|
|
GuideToPharmacology |
178101226 |
|
|
TTD |
PMID26651364-Compound-47 |
|
|
GuideToPharmacology |
404859108 |
|
|
TTD |
M-0004 |
|
|
GuideToPharmacology |
178102562 |
|
|
TTD |
Imidazo[1,2-a]pyridine derivative 1 |
|
|
TTD |
PMID25980951-Compound-3 |
|
|
GuideToPharmacology |
178103151 |
|
|
GuideToPharmacology |
135651504 |
|
|
GuideToPharmacology |
178100981 |
|
|
TEND |
DROTRECOGIN ALFA |
|
|
GuideToPharmacology |
381118853 |
|
|
TTD |
Isoxazole-based bicyclic compound 14 |
|
|
GuideToPharmacology |
135652248 |
|
|
TTD |
PMID28394193-Compound-26 |
|
|
GuideToPharmacology |
135651145 |
|
|
GuideToPharmacology |
249565608 |
|
|
GuideToPharmacology |
178100356 |
|
|
TTD |
Mannoside derivative 7 |
|
|
TTD |
GPX-150D |
|
|
GuideToPharmacology |
178102347 |
|
|
TTD |
PMID25772215-Compound-WO2012177618M6 |
|
|
TTD |
XEN-2174 |
|
|
TALC |
LY 2510924 |
|
|
TTD |
N-(benzimidazole/indole) benzoic acid derivative 2 |
|
|
TTD |
PMID28627961-Compound-41 |
|
|
TTD |
Peptide analog 6 |
|
|
TTD |
Chimeric Antigen Receptor Modified T cells Targeting CD19 |
|
|
GuideToPharmacology |
135649685 |
|
|
TdgClinicalTrial |
APD916 |
|
|
TTD |
ABT-767 |
|
|
TTD |
Isoxazole-based bicyclic compound 3 |
|
|
TTD |
Piperazine derivative 3 |
|
|
PharmGKB |
amifampridine phosphate |
|
|
GuideToPharmacology |
178101770 |
|
|
GuideToPharmacology |
178102743 |
|
|
GuideToPharmacology |
348353678 |
|
|
TTD |
PMID29338548-Compound-29 |
|
|
TTD |
PMID25991433-Compound-O2 |
|
|
GuideToPharmacology |
135650582 |
|
|
GuideToPharmacology |
135652560 |
|
|
GuideToPharmacology |
252166629 |
|
|
TTD |
TLC-388 |
|
|
GuideToPharmacology |
252827433 |
|
|
GuideToPharmacology |
178102228 |
|
|
GuideToPharmacology |
178100876 |
|
|
TTD |
Factor 8 |
|
|
GuideToPharmacology |
310264730 |
|
|
TTD |
AWD-12-281 |
|
|
GuideToPharmacology |
135652154 |
|
|
TTD |
1,2-diamino cyclopentane-based derivative 23 |
|
|
TTD |
Spiroimidazolone derivative 4 |
|
|
TTD |
US8592455, 90 |
|
|
GuideToPharmacology |
178100640 |
|
|
GuideToPharmacology |
135650952 |
|
|
GuideToPharmacology |
135650065 |
|
|
TTD |
TD-101 |
|
|
GuideToPharmacology |
178102849 |
|
|
TTD |
Fluciclatide F-18 |
|
|
TTD |
1,3-dihydroxy phenyl derivative 2 |
|
|
TTD |
PMID25522065-Compound-9 |
|
|
GuideToPharmacology |
252166678 |
|
|
JAX-CKB |
iCRT-3 |
|
|
GuideToPharmacology |
348353629 |
|
|
GuideToPharmacology |
252827538 |
|
|
TTD |
STX 64 |
|
|
TTD |
PMID25656651-Compound-18 |
|
|
GuideToPharmacology |
404859027 |
|
|
TdgClinicalTrial |
LY3009104 |
|
|
NCI |
CANDESARTAN CILEXETIL |
|
|
TTD |
PMID27376512-Compound-PG-11048 |
|
|
TTD |
Ad5FGF-4 |
|
|
GuideToPharmacology |
178102639 |
|
|
GuideToPharmacology |
178100698 |
|
|
GuideToPharmacology |
178100220 |
|
|
TTD |
Diazepinone derivative 3 |
|
|
GuideToPharmacology |
135652375 |
|
|
GuideToPharmacology |
178100305 |
|
|
GuideToPharmacology |
178103121 |
|
|
TTD |
Aflunov |
|
|
TTD |
Isoflavone derivative 6 |
|
|
TTD |
PMID29649907-Compound-10 |
|
|
TTD |
Efaproxyn |
|
|
TTD |
PMID29757691-Compound-8b |
|
|
GuideToPharmacology |
178100688 |
|
|
TTD |
NM-702 |
|
|
TTD |
Indole-based analog 14 |
|
|
TTD |
Ergoloid mesylate |
|
|
GuideToPharmacology |
135652482 |
|
|
ChemblInteractions |
CHEMBL1200349 |
|
|
TTD |
ARI-2243 |
|
|
TTD |
Cyclic octapeptide derivative 1 |
|
|
TTD |
Reovirus |
|
|
TTD |
Sulfonamide derivative 16 |
|
|
TTD |
Ceftolozane/tazobactam |
|
|
GuideToPharmacology |
178102473 |
|
|
TTD |
Pyridine derivative 18 |
|
|
TTD |
Phenylephrine hydrochloride gel |
|
|
PharmGKB |
XR9051 |
|
|
TTD |
Heteroaryl-azepine derivative 5 |
|
|
TTD |
PMID28766366-Compound-Scheme11 |
|
|
TdgClinicalTrial |
CINTREDEKIN BESUDOTOX |
|
|
GuideToPharmacology |
404859031 |
|
|
TTD |
ALN-VSP |
|
|
TTD |
Heterocycle-containing compound 5 |
|
|
TTD |
PMID26651364-Compound-7e |
|
|
GuideToPharmacology |
178102253 |
|
|
GuideToPharmacology |
404859014 |
|
|
TTD |
(-)-Phenserine |
|
|
TTD |
BLY719 |
|
|
TTD |
MLN8054 |
|
|
GuideToPharmacology |
178101551 |
|
|
NCI |
MACROLIDES |
|
|
GuideToPharmacology |
178103636 |
|
|
TTD |
Cyclopropane 1-carboxylic acid derivative 7 |
|
|
NCI |
TRP-2 |
|
|
NCI |
OPIOIDS |
|
|
PharmGKB |
protease inhibitors |
|
|
TTD |
PD-200390 |
|
|
GuideToPharmacology |
315661259 |
|
|
TTD |
VTP-43742 |
|
|
TTD |
MSH-372 |
|
|
GuideToPharmacology |
135650748 |
|
|
TTD |
US9650366, 9 |
|
|
TTD |
CX157 |
|
|
GuideToPharmacology |
223366039 |
|
|
GuideToPharmacology |
328083455 |
|
|
GuideToPharmacology |
178102414 |
|
|
TTD |
DP-b99 |
|
|
TTD |
Isoindoline derivative 5 |
|
|
TTD |
PMID10498202C1 |
|
|
GuideToPharmacology |
53801033 |
|
|
GuideToPharmacology |
178102380 |
|
|
TTD |
C 82 |
|
|
GuideToPharmacology |
135649969 |
|
|
GuideToPharmacology |
404859154 |
|
|
GuideToPharmacology |
135652303 |
|
|
TTD |
S32504 |
|
|
TTD |
MUC-1 CART cell immunotherapy |
|
|
TTD |
Bryostatin-1 |
|
|
GuideToPharmacology |
249565817 |
|
|
GuideToPharmacology |
135650879 |
|
|
TTD |
BI 860585 |
|
|
COSMIC |
Tyrosine kinase inhibitor - NS |
|
|
TTD |
Pyrazole derivative 8 |
|
|
TTD |
LY-2624587 |
|
|
TTD |
PMID26924192-Compound-20 |
|
|
TTD |
Lulizumab pegol |
|
|
TTD |
CART30 |
|
|
NCI |
MAGNESIUM CHLORIDE |
|
|
NCI |
RECOMBINANT INTERLEUKIN |
|
|
TTD |
OPB-51602 |
|
|
GuideToPharmacology |
178100342 |
|
|
TTD |
Ad-IL-12 DNA therapeutic |
|
|
TTD |
PMID26815044-Compound-126 |
|
|
GuideToPharmacology |
178102159 |
|
|
TTD |
Alkyl mannoside derivative 9 |
|
|
GuideToPharmacology |
178102666 |
|
|
TTD |
Pyridine-2,4-dicarboxylic acid analog 4 |
|
|
NCI |
TAG-72 |
|
|
GuideToPharmacology |
135652530 |
|
|
TTD |
US20160326143, 28 |
|
|
GuideToPharmacology |
135652390 |
|
|
GuideToPharmacology |
178101767 |
|
|
TTD |
PMID26161698-Compound-17 |
|
|
GuideToPharmacology |
178100611 |
|
|
GuideToPharmacology |
178102321 |
|
|
GuideToPharmacology |
374883855 |
|
|
GuideToPharmacology |
252166880 |
|
|
GuideToPharmacology |
135651070 |
|
|
GuideToPharmacology |
53801066 |
|
|
GuideToPharmacology |
178102291 |
|
|
TTD |
CLR457 |
|
|
TTD |
PMID26560530-Compound-8 |
|
|
GuideToPharmacology |
178103477 |
|
|
TTD |
PMID25684022-Compound-WO2008107444 |
|
|
TTD |
Anti-CD20-CAR vector-transduced autologous T cells |
|
|
TTD |
SSR-180575 |
|
|
GuideToPharmacology |
252827386 |
|
|
TTD |
EGFR CART |
|
|
TTD |
Tacrine-dihydropyridine hybrid derivative 1 |
|
|
TTD |
Sodium butyrate |
|
|
TEND |
METHADYL ACETATE |
|
|
TdgClinicalTrial |
KB002 |
|
|
TTD |
RXI-109 |
|
|
TTD |
PMID29053063-Compound-7b |
|
|
TTD |
Eraxis/Vfend |
|
|
GuideToPharmacology |
135652279 |
|
|
TTD |
VM-206 |
|
|
GuideToPharmacology |
135652744 |
|
|
TTD |
1,2,3,4-tetrahydroisoquinoline derivative 1 |
|
|
TTD |
PBT-2 |
|
|
TTD |
PMID26004420-Compound-WO2012058116C |
|
|
GuideToPharmacology |
135650844 |
|
|
GuideToPharmacology |
404859028 |
|
|
TTD |
Imidazopyridazine derivative 7 |
|
|
TTD |
Carbamate derivative 5 |
|
|
TTD |
Macrocycle derivative 7 |
|
|
TTD |
Quinoline carboxamide derivative 2 |
|
|
JAX-CKB |
BPTES |
|
|
TTD |
Insulin-detemir |
|
|
TTD |
Tetra-hydro-quinoline derivative 2 |
|
|
GuideToPharmacology |
178103157 |
|
|
TTD |
Ascrolimus |
|
|
TTD |
Pyrazolopyrimidine derivative 1 |
|
|
TdgClinicalTrial |
ALC-0061 |
|
|
JAX-CKB |
HER2 CAR-T cells |
|
|
TTD |
Pyrazolo[3,4-d]pyrimidine derivative 8 |
|
|
MyCancerGenome |
AUY922 |
|
|
GuideToPharmacology |
381118832 |
|
|
NCI |
OESTROGENS |
|
|
GuideToPharmacology |
178103578 |
|
|
TTD |
PMID28394193-Compound-11 |
|
|
TdgClinicalTrial |
STARGEN |
|
|
TTD |
AST-005 |
|
|
TdgClinicalTrial |
GALLAMINE TRIETHIODIDE |
|
|
GuideToPharmacology |
387065622 |
|
|
TdgClinicalTrial |
PA-401 |
|
|
TTD |
VAN-10-4-eluting stent |
|
|
TTD |
CBL0137 |
|
|
TdgClinicalTrial |
CCX168 |
|
|
TTD |
PMID28394193-Compound-49 |
|
|
TTD |
Benzoic acid linked peptide analog 5 |
|
|
GuideToPharmacology |
135652489 |
|
|
TTD |
Pyrrole derivative 4 |
|
|
TTD |
Tetra-hydro-1H-1,2,6-triazaazulene derivative 2 |
|
|
TTD |
Carbamide derivative 13 |
|
|
TTD |
MOR-202 |
|
|
TTD |
BHV-5000 |
|
|
TdgClinicalTrial |
DG031 |
|
|
TdgClinicalTrial |
SAR 1118 |
|
|
TTD |
KB-6806 |
|
|
GuideToPharmacology |
252166593 |
|
|
GuideToPharmacology |
135650765 |
|
|
TTD |
PMID25726713-Compound-45 |
|
|
TTD |
PMID26394986-Compound-11 |
|
|
TdgClinicalTrial |
ETHYL EICOSAPENTAENOIC ACID |
|
|
TTD |
Tetra-cyclic pyridophthalazinone derivative 1 |
|
|
GuideToPharmacology |
135650711 |
|
|
NCI |
HEPARAN SULFATE |
|
|
TTD |
PMID29671355-Compound-15 |
|
|
TTD |
Interferon alpha 2a |
|
|
TTD |
Retroviral vector-transduced autologous T cells to express anti-GPC3 CARs |
|
|
TTD |
W-198 |
|
|
GuideToPharmacology |
135650463 |
|
|
TTD |
PMID29473428-Compound-76 |
|
|
NCI |
DIPHOSPHONATE |
|
|
TEND |
VALPROIC ACID |
|
|
NCI |
PI3-KINASE INHIBITORS |
|
|
TTD |
PMID28270010-Compound-Figure24-a |
|
|
TTD |
GKT-137831 |
|
|
TTD |
PMID25666693-Compound-116 |
|
|
GuideToPharmacology |
223366031 |
|
|
TdgClinicalTrial |
BIIB014 |
|
|
NCI |
ASCORBIC ACID |
|
|
TTD |
JSM 6427 |
|
|
GuideToPharmacology |
249565915 |
|
|
TTD |
Sirna-027 |
|
|
TTD |
Terpyridineplatinum(II) complexe 2 |
|
|
TTD |
PMID25666693-Compound-132 |
|
|
TTD |
PMID28454500-Compound-13 |
|
|
TTD |
Naptumomab estafenatox |
|
|
TTD |
AKOS003197197 |
|
|
TTD |
Sphinx |
|
|
TTD |
Piperazinyl norbenzomorphane compound 3 |
|
|
TdgClinicalTrial |
TPI-ASM8 |
|
|
TTD |
Indomethacin analog 2 |
|
|
GuideToPharmacology |
252166800 |
|
|
TTD |
PMID26651364-Compound-6a |
|
|
TTD |
US8524917, 10 |
|
|
TTD |
M9831 |
|
|
GuideToPharmacology |
178103526 |
|
|
TTD |
Viquidacin |
|
|
GuideToPharmacology |
252827501 |
|
|
JAX-CKB |
AMG 232 |
|
|
JAX-CKB |
SD-093 |
|
|
TTD |
Methylnaltrexone bromide |
|
|
GuideToPharmacology |
310264686 |
|
|
TTD |
Activated recombinant FVII-albumin fusion protein |
|
|
GuideToPharmacology |
252827455 |
|
|
TTD |
DiabeCell |
|
|
GuideToPharmacology |
135652027 |
|
|
TTD |
PMID25666693-Compound-3 |
|
|
TTD |
PMID26924192-Compound-102 |
|
|
GuideToPharmacology |
310264679 |
|
|
TTD |
PF-4554878 |
|
|
TTD |
MER-3001 |
|
|
TTD |
PSI-938 |
|
|
NCI |
IMMUNOLOGICAL ADJUVANT |
|
|
TTD |
BIIB104 |
|
|
TTD |
BI 113823 |
|
|
TTD |
K-604 |
|
|
TTD |
PMID27599163-Compound-78 |
|
|
TTD |
SHAPE |
|
|
TTD |
7-azaindole derivative 7 |
|
|
GuideToPharmacology |
178102712 |
|
|
TTD |
Aryl mannoside derivative 11 |
|
|
TTD |
1,2-diamino cyclopentane-based derivative 10 |
|
|
GuideToPharmacology |
178101926 |
|
|
TTD |
PMID25522065-Compound-50 |
|
|
TdgClinicalTrial |
CARDIODILATIN |
|
|
GuideToPharmacology |
315661299 |
|
|
GuideToPharmacology |
178100880 |
|
|
TdgClinicalTrial |
DG071 |
|
|
CancerCommons |
SB939 |
|
|
TdgClinicalTrial |
ACP-104 |
|
|
GuideToPharmacology |
135652333 |
|
|
JAX-CKB |
Carboxyamidotriazole Orotate |
|
|
GuideToPharmacology |
381744916 |
|
|
TTD |
Patient-derived CD19- and CD22 specific CAR |
|
|
TTD |
OntecizumabAmatuximab |
|
|
TTD |
Quinoline and quinazoline derivative 8 |
|
|
GuideToPharmacology |
363894182 |
|
|
GuideToPharmacology |
135652140 |
|
|
TTD |
Sulfonamide derivative 1 |
|
|
GuideToPharmacology |
135650446 |
|
|
TTD |
BC11-28 |
|
|
GuideToPharmacology |
135652032 |
|
|
GuideToPharmacology |
404859088 |
|
|
GuideToPharmacology |
178102896 |
|
|
GuideToPharmacology |
178102161 |
|
|
TTD |
Diaminopyridine analog 5 |
|
|
TTD |
Alkyl mannoside derivative 11 |
|
|
TTD |
PMID27019002-Compound-50 |
|
|
TTD |
ALO-1567 |
|
|
GuideToPharmacology |
135651412 |
|
|
TTD |
KPL-716 |
|
|
TTD |
IMMU-114 |
|
|
CIViC |
ANTI-ERBB3 MONOCLONAL ANTIBODY AV-203 |
|
|
GuideToPharmacology |
135650401 |
|
|
GuideToPharmacology |
381118797 |
|
|
GuideToPharmacology |
252827419 |
|
|
TTD |
Biaryl mannoside derivative 9 |
|
|
GuideToPharmacology |
385612233 |
|
|
JAX-CKB |
KTN0073-IgG1 |
|
|
TTD |
Lutropin alfa |
|
|
GuideToPharmacology |
135651419 |
|
|
TTD |
XL999 |
|
|
TTD |
PMID29130358-Compound-Figure17(10) |
|
|
GuideToPharmacology |
374883879 |
|
|
GuideToPharmacology |
223366199 |
|
|
PharmGKB |
sodium benzoate / sodium phenylacetate |
|
|
TTD |
PMID28394193-Compound-27 |
|
|
TTD |
MK-7288 |
|
|
TTD |
Disulfide compound 2 |
|
|
GuideToPharmacology |
310264672 |
|
|
JAX-CKB |
IWR-1 |
|
|
GuideToPharmacology |
249565924 |
|
|
GuideToPharmacology |
249565721 |
|
|
GuideToPharmacology |
310264678 |
|
|
TTD |
PT005 |
|
|
JAX-CKB |
FOLFIRI |
|
|
TTD |
ZYH-1 |
|
|
NCI |
NITROGEN MUSTARD |
|
|
TTD |
PMID28594589-Compound-TABLE3C1 |
|
|
GuideToPharmacology |
135652023 |
|
|
GuideToPharmacology |
385612239 |
|
|
TTD |
Maleimides derivative 2 |
|
|
NCI |
CD271 |
|
|
TTD |
CRA1000 |
|
|
JAX-CKB |
PW12 |
|
|
NCI |
FTI |
|
|
TTD |
PMID25435179-Compound-WO2013059587(VI, 2nd set) |
|
|
GuideToPharmacology |
187051809 |
|
|
TTD |
Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7 |
|
|
TTD |
Fused aromatic compound 1 |
|
|
TTD |
Ethynyl compound 6 |
|
|
TTD |
PMID28394193-Compound-21 |
|
|
TTD |
N-phenyl-pyrimidin-4-amine derivative 1 |
|
|
TTD |
M4344 |
|
|
GuideToPharmacology |
310264717 |
|
|
GuideToPharmacology |
135652455 |
|
|
NCI |
IFO |
|
|
TTD |
Central azetidine derivative 2 |
|
|
TTD |
MER-5101 |
|
|
TTD |
US9181182, 47 |
|
|
GuideToPharmacology |
135650316 |
|
|
TTD |
YKP-GI |
|
|
TTD |
PMID25666693-Compound-63 |
|
|
GuideToPharmacology |
315661094 |
|
|
PharmGKB |
ethinyl estradiol |
|
|
TTD |
PMID28447479-Compound-4 |
|
|
TTD |
PMID25435179-Compound-WO2012106509Salermide |
|
|
TdgClinicalTrial |
NRX-5183 |
|
|
GuideToPharmacology |
135649808 |
|
|
GuideToPharmacology |
252166738 |
|
|
TTD |
Indole-based analog 5 |
|
|
TTD |
NCX 1022 |
|
|
NCI |
RECOMBINANT HUMAN GROWTH HORMONE |
|
|
TTD |
Turoctocog alfa |
|
|
GuideToPharmacology |
404859120 |
|
|
GuideToPharmacology |
135652620 |
|
|
GuideToPharmacology |
178102662 |
|
|
TTD |
Benzamide derivative 7 |
|
|
TTD |
PMID27376512-Compound-Figure3CN |
|
|
GuideToPharmacology |
135650660 |
|
|
TTD |
ProstaVac |
|
|
JAX-CKB |
PF-573228 |
|
|
GuideToPharmacology |
252166888 |
|
|
GuideToPharmacology |
178101761 |
|
|
NCI |
BUPROPION HCL |
|
|
GuideToPharmacology |
135650947 |
|